Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Clinical trial NCT04464434 · COMPLETED

Trial details

NCT number: NCT04464434
Sponsor: UMC Utrecht
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Sclerosis Systemic Scleroses, Diffuse Scleroderma Scleroderma, Diffuse Autologous Stem Cell Transplantation Cyclophosphamide Mycophenolate Mofetil Treatment Strategy

Start date: 2020-09-17
Primary completion: 2026-03-19
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.